首页 | 本学科首页   官方微博 | 高级检索  
检索        

刚地弓形虫ROP2-P30复合重组蛋白疫苗对BALB/c小鼠免疫保护性的研究
引用本文:张佃波,周林涛,王海防,刘丽娟,陈锡欣,江洪涛,王用斌,刘克义.刚地弓形虫ROP2-P30复合重组蛋白疫苗对BALB/c小鼠免疫保护性的研究[J].中国病原生物学杂志,2008,3(10).
作者姓名:张佃波  周林涛  王海防  刘丽娟  陈锡欣  江洪涛  王用斌  刘克义
作者单位:山东省寄生虫病防治研究所,山东济宁,272033
摘    要:目的用刚地弓形虫ROP2-P30复合重组蛋白疫苗免疫BALB/c小鼠观察对机体的影响,为研制安全有效的弓形虫疫苗奠定基础。方法PCR方法从刚地弓形虫基因组中扩增出ROP2和P30片段,将这两个片段分别亚克隆至pET-30a原核表达载体中,表达出ROP2-P30复合重组蛋白。用蛋白疫苗免疫BALB/c小鼠,ELISA检测免疫小鼠后体液中抗体和细胞因子的变化,观察攻击试验小鼠的的死亡率。结果ROP2-P30复合重组蛋白疫苗免疫BALB/c小鼠诱导机体产生大量的IgM、IgG抗体和IFN-γ、IL-2及IL-4细胞因子。攻击试验表明,复合重组蛋白免疫组和对照组相比,小鼠的存活时间明显延长。结论ROP2-P30复合重组蛋白免疫BALB/c小鼠诱导其产生高水平的体液和细胞免疫应答,该复合重组蛋白是抗刚地弓形虫感染的候选疫苗之一。

关 键 词:ROP2-P30复合重组蛋白疫苗  抗体  细胞因子  刚地弓形虫

PROTECTIVE EFFECT OF MULTIPLE RECOMBINANT ANTIGENSAGAINST TOXOPLASMOSIS IN MICE
ZHANG Dian-bo,ZHOU Lin-tao,WANG Hai-fang,LIU Li-juan,CHEN Xi-xin,JIANG Hong-tao,WANG Yong-bin,LIU Ke-yi.PROTECTIVE EFFECT OF MULTIPLE RECOMBINANT ANTIGENSAGAINST TOXOPLASMOSIS IN MICE[J].Journal of Pathogen Biology,2008,3(10).
Authors:ZHANG Dian-bo  ZHOU Lin-tao  WANG Hai-fang  LIU Li-juan  CHEN Xi-xin  JIANG Hong-tao  WANG Yong-bin  LIU Ke-yi
Abstract:Objective To observe the effect of multiple recombinant antigen vaccine on BALB/c mice in order to lay foundation for developing an effective and safe protein vaccine against Toxoplasma gondii. Methods The genes encoding ROP2 and P30 were amplified from T. gondii genome by PCR. Two genes fragments were subcloned into the expression vector, respectively. The multiple recombinant antigen (ROP2-P30) of T. gondii was expressed in vitro. The immune response of host to the antigen was investigated by detection of specific antibodies reaction to ROP2-P30 recombinant protein and production of cytokines. Mice were immunized with multiple recombinant protein and challenged with lethal strain of T. gondii RH. Results BALB/c mice intramuscularly immunized with multiple recombinant protein induced specific high titer of IgM and IgG antibodies as well as IFN-γ, IL-2 and IL-4 cytokines in mice. In contrast, IgA was detected in low titer, whereas no IL-12 and IL-6 were detected. Moreover, the multiple recombinant protein induced mice to produce a long-lasting protection against a lethal challenge with the highly virulent T. gondii RH strain compared to the control group. Conclusion The immune protection induced by ROP2-P30 recombinant protein against T.gondii may be regulated by both hormone- and cell-mediated immune response. ROP2-P30 recombinant protein may be an excellent vaccine candidate against T. gondii.
Keywords:Multiple recombinant protein vaccination  specific antibodies  cytokines  Toxoplasma gondii
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号